GPT and fatty liver disease: Patti et al. (94) analyzed the effectiveness of a 2-month intervention with EVOO (32 g/day) in subjects with MS and associated liver steatosis, showing a reduction of alanine aminotransferase levels (p = 0.029) after intervention, and considered it a possible indirect demonstration of liver steatosis reduction.